Skip to main content
. 2022 Mar 23;9(2):ENEURO.0434-21.2022. doi: 10.1523/ENEURO.0434-21.2022

Figure 4.

Figure 4.

Effects of agmatine on cisplatin-induced hair cell loss (a) and ROS level (c) in the middle turns of the cochleae explant. Quantification of myosin 7a-positive (b) and DCFH-DA-positive (d) hair cells. Scale bar: 20 μm. Data were represented as mean ± SD, n = 6 for each group; *p <0.05, **p <0.01 compared with control group; #p <0.05, ##p <0.01 compared with cisplatin group.